We are pleased to share a recent feature article on OncoSil Medical Limited published by Biotech Daily on 24 July 2026, which provides an independent overview of the company’s progress, commercial opportunities and near-term catalysts.

We encourage you to read the publication for a detailed perspective on the company's achievements and opportunities ahead.

Important Notice:

The report has been prepared by Biotech Daily. It is independent third-party research and reflects the views of the author. Investors should consider their own circumstances and seek professional advice before making any investment decisions.